It has been proved that Rad51 G135C allele is associated with a higher survival time and a better prognosis in lung cancer patients treated with platinum-paclitaxel / gemcitabine Wrst line chemotherapy [16]. The gene discussed is RAD51; the disease is lung carcinoma.